HIGHLIGHTS
- who: Thomas Bardol and colleagues from the Department of Digestive Surgery and Transplantation, Montpellier University Hospital, University of Montpellier-Nimes, du Doyen Gaston Giraud, Montpellier, France have published the paper: Survival after Multimodal Treatment Including Surgery for Metastatic Esophageal Cancer: A Systematic Review, in the Journal: Cancers 2022, 14, 3956. of /2022/
- what: The aim of this systematic review is to assess the survival outcome of surgically treated metastatic esophageal cancer patients. The analysis demonstrates a three-year overall survival rate of 23% (CI 95% 17-31) among patients undergoing surgery. All the studies were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.